Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Immobilized Whole Cell. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN106047950A details enzymatic reduction for high-purity intermediates. Offers cost reduction and scalable supply chain solutions for global pharmaceutical manufacturing.
Novel immobilized cell method ensures high purity and cost efficiency for pharmaceutical intermediates manufacturing supply chains.
Patent CN104059952A details immobilized cell catalysis for high-purity intermediates. This method offers significant cost reduction and supply chain reliability for global manufacturers.